High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
1.53B
+4.49%
3.428
+9.16%
1.56B
+5.16%
3.526
+14.84%
1.58B
+6.7%
3.719
+13.73%
Estimates Revision
The market is revising No Change the revenue expectations for Globe Life Inc. (GL) for FY2025, with the revenue forecasts being adjusted by -0% over the past three months. During the same period, the stock price has changed by -6.43%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-6.43%
In Past 3 Month
8 Analyst Rating
Wall Street analysts forecast GL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GL is 167.63 USD with a low forecast of 145.00 USD and a high forecast of 182.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
1 Hold
0 Sell
Strong Buy
Current: 130.820
Low
145.00
Averages
167.63
High
182.00
Current: 130.820
Low
145.00
Averages
167.63
High
182.00
Morgan Stanley
Bob Huang
Overweight
maintain
$179 -> $177
2025-11-17
Reason
Morgan Stanley
Bob Huang
Price Target
$179 -> $177
2025-11-17
maintain
Overweight
Reason
Morgan Stanley analyst Bob Huang lowered the firm's price target on Globe Life to $177 from $179 and keeps an Overweight rating on the shares. The firm updated models in the insurance space post the Q3 reports. Life insurance earnings reports were better than what share price reactions would suggest, the analyst tells investors in a research note. For property and casualty, Morgan Stanley sees a softening cycle heading into 2026.
Keefe Bruyette
Outperform
maintain
$160 -> $162
2025-10-28
Reason
Keefe Bruyette
Price Target
$160 -> $162
2025-10-28
maintain
Outperform
Reason
Keefe Bruyette raised the firm's price target on Globe Life to $162 from $160 and keeps an Outperform rating on the shares. The primary near-term risk is a lack of further catalysts, the analyst tells investors in a research note.
Truist
Mark Hughes
Buy
maintain
$150 -> $158
2025-10-24
Reason
Truist
Mark Hughes
Price Target
$150 -> $158
2025-10-24
maintain
Buy
Reason
Truist analyst Mark Hughes raised the firm's price target on Globe Life to $158 from $150 and keeps a Buy rating on the shares after its Q3 earnings beat. The firm is raising its price target, which assumes the stock trades at just under 10.5-times next year's earnings, still below its long-term norm in the low-double-digits, the analyst tells investors in a research note.
Wells Fargo
Overweight
maintain
$172 -> $170
2025-10-24
Reason
Wells Fargo
Price Target
$172 -> $170
2025-10-24
maintain
Overweight
Reason
Wells Fargo lowered the firm's price target on Globe Life to $170 from $172 and keeps an Overweight rating on the shares. The firm notes Globe Life was volatile as weak top line growth and lackluster agent count growth was partially offset by management commentary on strong life margins for 2026 and higher buybacks.
Morgan Stanley
Overweight
maintain
$166 -> $171
2025-08-18
Reason
Morgan Stanley
Price Target
$166 -> $171
2025-08-18
maintain
Overweight
Reason
Morgan Stanley raised the firm's price target on Globe Life to $171 from $166 and keeps an Overweight rating on the shares. Following Q2 results, the firm is updating its price targets for stocks in the Life Insurance segment under its coverage, the analyst tells investors. Nearly half of the life insurers under its coverage beat expectations on a reported basis and most exceeded expectations on a core basis, the firm adds. Morgan Stanley notes the earnings beats were largely driven by selective favorable underwriting, better than expected performance of macro-sensitive segments, or both.
Morgan Stanley
Equal Weight -> Overweight
upgrade
$135 -> $166
2025-08-05
Reason
Morgan Stanley
Price Target
$135 -> $166
2025-08-05
upgrade
Equal Weight -> Overweight
Reason
Morgan Stanley upgraded Globe Life to Overweight from Equal Weight with a price target of $166, up from $135. The firm believes the end of SEC and DOJ investigations should remove significant uncertainty on the the shares. With the investigative headwinds removed, investor focus should shift back to Globe Life's fundamentals and "steady" earnings growth, the analyst tells investors in a research note. Morgan Stanley sees a path to multiple expansion for the shares.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Globe Life Inc (GL.N) is 8.96, compared to its 5-year average forward P/E of 10.54. For a more detailed relative valuation and DCF analysis to assess Globe Life Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
10.54
Current PE
8.96
Overvalued PE
12.47
Undervalued PE
8.62
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
9.47
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
11.06
Undervalued EV/EBITDA
7.89
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
1.82
Current PS
0.00
Overvalued PS
2.05
Undervalued PS
1.59
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 1656.78% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 1440.51% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 1656.78% over the last month.
Sold
Bought
GL News & Events
Events Timeline
(ET)
2025-10-28
09:02:46
Globe Life Partners with North Texas Food Bank for Three-Year Initiative
2025-10-22 (ET)
2025-10-22
16:14:08
Globe Life announces Q3 operating EPS of $4.81, surpassing consensus estimate of $4.54.
2025-10-07 (ET)
2025-10-07
09:13:58
December Gold Surpasses $4,000 an Ounce, Boosting Gold Mining Stocks
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/20251129074214_854fed820ed79d2e1cb2432e98643678.jpg)
Preview
7.0
11-29PRnewswireGlobe Life Inc. Investigated for Potential Breach of Fiduciary Duties by Executives
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/71f73b4a10f49ef14593d52cf743589c2d6b42613aefc3e2de4e7f84507b81f1.png)
Preview
6.0
11-13Yahoo FinanceAM Best Reconfirms Credit Ratings for Globe Life Inc. and Its Subsidiaries
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/a3b24fb644e98794b582131510fb24ea635eeed23376f1d038e6306b44e6a987.png)
Preview
8.0
11-07PRnewswireGLOBE LIFE INC. DECLARES DIVIDEND
Sign Up For More News
People Also Watch
FAQ
What is Globe Life Inc (GL) stock price today?
What is Globe Life Inc (GL)'s business?
What is the price predicton of GL Stock?
What is Globe Life Inc (GL)'s revenue for the last quarter?
What is Globe Life Inc (GL)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Globe Life Inc (GL)'s fundamentals?
How many employees does Globe Life Inc (GL). have?